The evaluation and revision of the general pharmaceutical legislation is the opportunity to create a future-proof, patient-oriented and leading life science and biotechnology sector in the EU.
With the Green Deal, the EU has set an ambitious strategy towards climate neutrality, transitioning to a circular economy and a more sustainable food system
Save the date for this 14th edition!EFIB is the market leading annual event in Europe for Industrial Biotechnology and the Bioeconomy. Visit the dedicated website to […]
The European Health and Digital Executive Agency (HaDEA) with the support of the European Commission organizes an info session to present three HERA’s public procurement calls […]
EuropaBio, the European Association for Bioindustries, is proud to continue our platform for engaging patient and industry alike on pertinent healthcare debates: the Patient Bio-Forum. In […]
At the time of the 25th Anniversary of EuropaBio, we would like to look to the future and the green transition that will shape healthcare for us all.
HBio is a strong innovation moderator, connecting and supporting industry and academia partners to develop innovative and impact science. The Hellenic Biocluster delivers connectivity to the […]
Join the inaugural Rare Conversations Conference aimed at facilitating essential discussion on the future of the rare disease and OMP ecosystem involving leading experts.The event will […]
Biotechnology and digital are getting closer. Due to the high development of both segments, Slovenia has a great global opportunity in this convergent field of medicine. […]
The European Bioplastics Conference, taking place from 30 November to 1 December 2021 in Berlin, is the leading business and discussion forum in Europe for the […]
The ‘EFIB 2021 Vienna Statement’ marked the launch of an annual call to action from EuropaBio members, with policy asks and actions critical in the short […]
December 2nd, major industrial players, small to medium sized enterprises, government officials and research and technology organisations from all over the world will join Biorizon Shared […]
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
